Top Broker Regulation Stories
Rare disease drugmakers join in worries over GOP health overhaul
By Doni BloomfieldTreatments for rare diseases brought in $114 billion in worldwide sales last year and drugmakers big and small are increasingly banking on them to boost revenue.
